MedPageToday
MedPage Today) — BOSTON — Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common forms of chronic inducible urticaria, a dose-ranging phase II trial showed.
In patients…
Read More
Novel Drug for Chronic Inducible Urticaria Delivers in Mid-Stage Trial
Sharie Drews
17:19
MedPage Today) — BOSTON — Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common forms of chronic inducible urticaria, a dose-ranging phase II trial showed. In patients…
